Abstract
Genital warts caused by Human Papilloma Virus (HPV) are the most common sexually transmitted disease in the United States. Prevalence of genital infection with any HPV type was 42.5% among United States adults aged 18–59 years during 2013–2014 (McQuillan et al, Prevalence of HPV in Adults aged 18–69; United States 2011–2014. NCHS Data Brief, No 280, Hyattsville: National Center for Health Statistics, 2017). High-risk genital HPV prevalence was 22.7% in the total population, with 20.4% among women (McQuillan et al, Prevalence of HPV in Adults aged 18–69; United States 2011–2014. NCHS Data Brief, No 280, Hyattsville: National Center for Health Statistics, 2017). An increased prevalence for progression to cervical cancer has been correlated with cigarette smoking, multiple sex partners, immunosuppression (HIV or high-dose steroid use), three or more pregnancies, and long-term use of contraceptives (What are the risk factors for Cervical Cancer? https://www.cdc.gov/cancer/knowledge/provider-education/cervical/risk-factors.htm. Accessed 24 June 2018).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McQuillan G, Kruszon-Moran D, Markowitz LE, Unger E, Paulose-Ram R. Prevalence of HPV in Adults aged 18-69; United states 2011-2014. NCHS Data Brief, No 280. Hyattsville: National Center for Health Statistics; 2017.
What are the risk factors for Cervical Cancer? https://www.cdc.gov/cancer/knowledge/provider-education/cervical/risk-factors.htm. 2017. Accessed 24 June 2018.
Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination — updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–8.
Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GWK, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356(19):1928–43.
Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137(3):1–9.
Eschenbach D. Pelvic and sexually transmitted diseases. In: Gibbs RS, Karlan BY, Haney AR, Nygaard IE, editors. Danforth’s obstetrics and gynecology: Lippincott Williams & Wilkins; 2008.
Podophloxin description; RxList: available at https://www.rxlist.com/podofilox-topical-solution-drug.htm. Accessed 24 June 2018.
Gross G, Meyer K-G, Pres H, Thielert C, Tawfik H, Mescheder A. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon® E in the treatment of external genital warts. J Eur Acad Dermatol Venereol. 2007;21(10):1404–12.
Veregen description; Rxlist: the internet drug Index. 2007. Available at: http://www.rxlist.com/cgi/generic/veregen.htm. Accessed 24 June 2018.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Heath, C.B. (2020). Treatment of Genital Warts. In: Heath, C., Sulik, S. (eds) Primary Care Procedures in Women's Health. Springer, Cham. https://doi.org/10.1007/978-3-030-28884-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-030-28884-6_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28883-9
Online ISBN: 978-3-030-28884-6
eBook Packages: MedicineMedicine (R0)